Drug Profile
Research programme: corticotropin releasing factor receptor 1 antagonists - Ligand
Alternative Names: AVE 4579; CRF-1 - Ligand PharmaceuticalsLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Neurogen Corporation
- Developer Ligand Pharmaceuticals
- Class
- Mechanism of Action Corticotropin releasing factor receptor 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Anxiety-disorders in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Major depressive disorder in USA
- 21 Jan 2010 Preclinical development is ongoing in the US